Conversion therapy of hepatocellular carcinoma: some pivotal issues to be resolved
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 2
Abstract
Progress in the systemic therapies, represented by the molecular target therapies and immune checkpoint inhibitors (ICIs), have significantly improved the prognosis of unresectable hepatocellular carcinoma (uHCC), but long term survial remains limitted. As one of the major combination of systemic and surgical therapies, conversion therapy provides potentially curative opportunity to some uHCC patients. It is widely reported from different domestic centers.The first Chinese expert consensus about it was released in 2021. Yet at the same time, there are many key issues in the practice and theory remains to be resolved. Actively thinking, exploring and finally resolving these issues are essential for establishing and promoting the standardized theoretical system of uHCC conversion therapy.
Authors and Affiliations
Lei ZHAO, Jingtao ZHONG, Huichuan SUN
Development and prospects of ERCP in China
Endoscopic retrograde cholangio-pancreatography (ERCP) is an interventional endoscopic technique aimed at the diagnoses and treatment of biliary and pancreatic diseases under the guidance of endoscopy and X-ray ima-ging....
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in treatment of peritoneal metastatic gastric cancer: current status and future prospects
Prevention and treatment of anastomotic leakage after laparoscopic anterior resection of low rectal cancer
Anastomotic leakage (AL) is one of the inevitable and severe complications after laparoscopic-assisted anterior resection of low rectal cancer. With the improvement of surgical technology and cognitive concept, the posit...
Efficacy with prognostic value of postoperative prophylactic hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer
[Objective] To explore the efficacy with prognostic value of postoperative prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for locally advanced gastric cancer with clinical stage cT3-4NxM0. [Methods] A ret...
Influence of neoadjuvant radiotherapy combined with immunotherapy on minimally invasive surgeries for rectal cancer
The current domestic and international guidelines recommend neoadjuvant chemoradiation or total neoadjuvant therapy followed by radical surgery for mid-low locally advanced rectal cancer. In recent years, the significant...